drugset / Trial / NCT06666270
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 as monotherapy in adult patients with advanced solid tumors
Timeline
- Start
- 2024-11-21
- Primary completion
- 2026-06-30
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYN818 | Unknown | — | Oral |